Bioventix PLC

BVXP.L · LSE
Analyze with AI
6/30/2025
6/30/2024
6/30/2023
6/30/2022
Market Cap£143,572£228,360£200,670£179,721
- Cash£5,079£5,999£5,716£6,127
+ Debt£0£0£0£0
Enterprise Value£138,493£222,361£194,955£173,594
Revenue£13,116£13,607£12,816£11,719
% Growth-3.6%6.2%9.4%
Gross Profit£11,917£12,681£11,859£10,865
% Margin90.9%93.2%92.5%92.7%
EBITDA£10,166£10,740£10,199£9,422
% Margin77.5%78.9%79.6%80.4%
Net Income£7,584£8,097£8,372£7,674
% Margin57.8%59.5%65.3%65.5%
EPS Diluted1.431.531.581.46
% Growth-6.5%-3.2%8.2%
Operating Cash Flow£7,032£8,344£7,903£7,562
Capital Expenditures-£19-£16-£11-£12
Free Cash Flow£7,013£8,328£7,893£7,550